Preliminary studies suggest conolidine may perhaps inhibit particular ion channels, reducing neuronal excitability and limiting discomfort alerts. This system is especially pertinent in neuropathic suffering, wherever abnormal signaling triggers persistent pain. Additionally, conolidine appears to influence G protein-coupled receptor (GPCR) pathway